Hepatic ischaemia-reperfusion injury from bench to bedside

British Journal of Surgery

Volumn 97, Issue 10, 2010, Pages 1461-1475

  Bahde, R ^a   Spiegel, H U ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; GLUCOSE; VASODILATOR AGENT;

HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC PRECONDITIONING; LIVER RESECTION; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; REVIEW;

ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; GLUCOSE; HEPATECTOMY; HUMANS; INFUSIONS, INTRAVENOUS; ISCHEMIC PRECONDITIONING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPERFUSION INJURY; VASODILATOR AGENTS;

EID: 77957014029     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7176     Document Type: Review

References (143)

1. Nagorney DM, van Heerden JA, Ilstrup DM, Adson MA. Primary hepatic malignancy: surgical management and determinants of survival. Surgery 1989; 106: 740-748.
2. Agarwal N, Murphy JG, Cayten CG, StahlWM. Blood transfusion increases the risk of infection after trauma. Arch Surg 1993; 128: 171-176.
3. Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H et al. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery 1994; 115: 303-309.
4. Stephenson KR, Steinberg SM, Hughes KS, Vetto JT, Sugarbaker PH, Chang AE. Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases. Ann Surg 1988; 208: 679-687.
5. Cunningham JD, Fong Y, Shriver C, Melendez J, Marx WL, Blumgart LH. One hundred consecutive hepatic resections: blood loss, transfusion and operative technique. Arch Surg 1994; 129: 1050-1056.
6. Strasberg SM, Drebin JA, Linehan D. Use of a bipolar vessel-sealing device for parenchymal transection during liver surgery. J Gastrointest Surg 2002; 6: 569-574.
7. Takayama T, Makuuchi M. Intraoperative ultrasonography and other techniques for segmental resections. Surg Oncol Clin N Am 1996; 5: 261-269.
8. Lortat-Jacob JL, Robert HG, Henry C. Un cas d'hépatectomie droite réglée. Mem Acad Chir (Paris) 1952; 78: 244-251.
9. Tung TT. Les Résections Majeures et Mineures du Fois. Masson: Paris, 1979.
10. Man K, Fan ST,Ng IO, Lo CM, Liu CL, Wong J. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg 1997; 226: 704-711.
11. van Gulik TM, de Graaf W, Dinant S, Busch OR, Gouma DJ. Vascular occlusion techniques during liver resection. Dig Surg 2007; 24: 274-281.
12. Nakajima Y, Shimamura T, Kamiyama T, Matsushita M, Sato N, Todo S. Control of intraoperative bleeding during liver resection: analysis of a questionnaire sent to 231 Japanese hospitals. Surg Today 2002; 32: 48-52.
13. van der Bilt JD, Livestro DP, Borren A, van Hillegersberg R, Borel Rinkes IH. European survey on the application of vascular clamping in liver surgery. Dig Surg 2007; 24: 423-435.
14. Rahbari NN, WenteWN, Schemmer P, Diener MK, Hoffmann K, Mottschall E et al. Systematic review and meta-analysis of the effect of portal triad clamping and outcome after hepatic resection. Br J Surg 2008; 95: 424-432.
15. Caldwell-Kenkel JC, Currin RT, Coote A, Thurman RG, Lemasters JJ. Rerperfusion injury to endothelial cells after cold storage of rat livers: protection by mildly acidic pH and lack of protection by antioxidants. Transplant Int 1995; 8: 77-85.
16. Wanner GA, ErtelW, Müller P, Hofer Y, Leiderer R, Menger MD et al. Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation. Shock 1996; 5: 34-40.
17. Selzner N, Rudiger H, Graf H, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology 2003; 125: 917-936.
18. Zwacka RM, Zhang Y, ZhouW, Halldorson J, Engelhardt JF. Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor kappaB independently of IkappaB degradation. Hepatology 1998; 28: 1022-1030.
19. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003; 284: G15-G26. (Pubitemid 36076246)
20. Pannen BH, Al-Adili F, Bauer M, Clemens MG, Geiger KK. Role of endothelins and nitric oxide in hepatic reperfusion injury in the rat. Hepatology 1998; 27: 755-764.
21. Vollmar B,Glasz J, Leiderer R, Post S, MengerMD. Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. Am J Pathol 1994; 145: 1421-1431.
22. Ezaki T, Seo Y, Tomoda H, Furusawa M, Kanematsu T, Sugimachi K. Partial hepatic resection under intermittent hepatic inflow occlusion in patients with chronic liver disease. Br J Surg 1992; 79: 224-226.
23. Serviddio G, Bellanti F, Tamborra R, Rollo T, Capitanio N, Romano AD et al. Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury. Gut 2008; 57: 957-965.
24. Massip-Salcedo M, Zaouali MA, Padrissa-Altés S, Casillas-Ramirez A, Rodés J, Roselló-Catafau J et al. Activation of peroxisome proliferator-activated receptor-alpha inhibits the injurious effects of adiponectin in rat steatotic liver undergoing ischemia-reperfusion. Hepatology 2008; 47: 461-472.
25. Huet PM, Giroux L, Laurens M, Crenesse D. Effect of cold ischemia-warm reperfusion on the cirrhotic rat liver. Liver Transpl 2008; 14: 486-493.
26. Kuddus RH, Nalesnik MA, Subbotin VM, Rao AS, Gandhi CR. Enhanced synthesis and reduced metabolism of endothelin-1 (ET-1) by hepatocytes - an important mechanism of increased endogenous levels of ET-1 in liver cirrhosis. J Hepatol 2000; 33: 725-732.
27. Tsuchiya Y, Suzuki S, Inaba K, Sakaguchi T, Baba S, Miwa M et al. Impact of endothelin-1 on microcirculatory disturbance after partial hepatectomy under ischemia/reperfusion in thioacetamide-induced cirrhotic rats. J Surg Res 2003; 111: 100-108.
28. Li SQ, Liang LJ, Huang JF, Li Z. Hepatocyte apoptosis induced by hepatic ischemia-reperfusion injury in cirrhotic rats. Hepatobiliary Pancreat Dis Int 2003; 2: 102-105.
29. Manekeller S, Sioutis M, Hirner A, Minor T. [Influence of neoadjuvant chemotherapy on liver integrity and ischemic tolerance.] Z Gastroenterol 2008; 46: 17-21.
30. Carini R, Albano E. Recent insights on the mechanisms of liver preconditioning. Gastroenterology 2003; 125: 1480-1491.
31. Peralta C, Hotter G, Closa D, Gelpí E, Bulbena O, Roselló-Catafau J. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of nitric oxide and adenosine. Hepatology 1997; 25: 934-937.
32. Redaelli CA, Tian YH, Schaffner T, Ledermann M, Baer HU, Dufour JF. Extended preservation of rat liver graft by induction of heme oxygenase-1. Hepatology 2002; 35: 1082-1092.
33. Peralta C, Fernández L, Panés J, Prats N, Sans M, Piqué JM et al. Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat. Hepatology 2001; 33: 100-113.
34. Hardy KJ, McClure DN, Subwongcharoen S. Ischaemic preconditioning of the liver: a preliminary study. Aust N Z J Surg 1996; 66: 707-710.
35. Peralta C, Closa D, Xaus C, Gelpí E, Roselló-Catafau J, Hotter G. Hepatic preconditioning in rats is defined by a balance of adenosine and xanthine. Hepatology 1998; 28: 768-773.
36. Kanoria S, Jalan R, Seifalian AM, Williams R, Davidson BR. Protocols and mechanisms for remote ischemic preconditioning: a novel method for reducing ischemia reperfusion injury. Transplantation 2007; 84: 445-458.
37. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 1993; 87: 893-899.
38. Kanoria S, Jalan R, Davies NA, Seifalian AM, Williams R, Davidson BR. Remote ischaemic preconditioning of the hind limb reduces experimental liver warm ischaemia-reperfusion injury. Br J Surg 2006; 93: 762-768.
39. Isozaki H, Adam R, GigouM, Szekely AM, ShenM, Bismuth H. Experimental study of the protective effect of intermittent hepatic pedicle clamping in the rat. Br J Surg 1992; 79: 310-313.
40. vanWagensveld BA, van Gulik TM, Gelderblom HC, Scheepers JJ, Bosma A, Endert E et al. Prolonged continuous or intermittent vascular inflow occlusion during hemihepatectomy in pigs. Ann Surg 1999; 229: 376-384.
41. Hewitt G, Halliday I, McCaigue M, Campbell G, Rowlands B, Diamond T. Mortality, endotoxaemia and cytokine expression after intermittent and continuous hepatic ischaemia. Br J Surg 1995; 82: 1424-1426.
42. Ozmen MM, Oruc MT, Besler HT, Kulah B, Safali M, Polat A et al. Comparison of the effects of continuous and intermittent portal triad occlusion (PTO) in rats. Hepatogastroenterology 2003; 50: 2127-2132.
43. Uchinami M, Muraoka R, Horiuchi T, Tabo T, Kimura N, Naito Y et al. Effect of intermittent hepatic pedicle clamping on free radical generation in the rat liver. Surgery 1998; 124: 49-56.
44. Furrer K, Deoliveira ML, Graf R, Clavien PA. Improving outcome in patients undergoing liver surgery. Liver Int 2007; 27: 26-39.
45. Rüdiger HA, Kang KJ, Sindram D, Riehle HM, Clavien PA. Comparison of ischemic preconditioning and intermittent and continuous occlusion in the murine liver. Ann Surg 2002; 235: 400-407.
46. Vajdová K, Heinrich S, Tian Y, Graf R, Clavien PA. Ischemic preconditioning and intermittent clamping improve murine hepatic microcirculation and Kupffer cell function after ischemic injury. Liver Transpl 2004; 10: 520-528.
47. Smyrniotis V, Kostopanagiotou G, Theodoraki K, Farantos C, Arkadopoulos N, Gamaletsos E et al. Ischemic preconditioning versus intermittent vascular inflow control during major liver resection in pigs. World J Surg 2005; 29: 930-934.
48. Schiesser M,Wittert A, Nieuwenhuijs VB, Morphett A, Padbury RT, Barritt JG. Intermittent ischemia but not ischemic preconditioning is effective in restoring bile flow after ischemia reperfusion injury in the livers of aged rats. J Surg Res 2009; 152: 61-68.
49. Saidi RF, Chang J, Brooks S, Nalbantoglu I, Adsay V, Jacobs MJ. Ischemic preconditioning and intermittent clamping increase the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Transplant Proc 2007; 39: 3010-3014.
50. Jang JH, Kang KJ, Kang Y, Lee IS, Graf R, Clavien PA. Ischemic preconditioning and intermittent clamping confer protection against ischemic injury in the cirrhotic mouse liver. Liver Transpl 2008; 14: 980-988. (Pubitemid 352003897)
51. Wheeler MD, Katuna M, Smutney OM, Froh M, Dikalova A, Mason RP et al. Comparison of the effect of adenoviral delivery of three superoxide dismutase genes against hepatic ischemia-reperfusion injury. Hum Gene Ther 2001; 12: 2167-2177.
52. Yabe Y, Nishikawa M, Tamada A, Takakura Y, Hashida M. Targeted delivery and improved therapeutic potential of catalase by chemical modification: combination with superoxide dismutase derivatives. J Pharmacol Exp Ther 1999; 289: 1176-1184.
53. Giakoustidis D, Kontos N, Iliadis S, Papageorgiou G, Tsantilas D, Spyridis C et al. Severe total hepatic ischemia and reperfusion: relationship between very high alpha-tocopherol uptake and lipid peroxidation. Free Radic Res 2001; 35: 103-109.
54. Seo MY, Lee SM. Protective effect of low dose of ascorbic acid on hepatobiliary function in hepatic ischemia/reperfusion in rats. J Hepatol 2002; 36: 72-77.
55. Schauer RJ, Gerbes AL, Vonier D, Meissner H, Michl P, Leiderer R et al. Glutathione protects the rat liver against reperfusion injury after prolonged warm ischemia. Ann Surg 2004; 239: 220-231.
56. Glantzounis GK, YangW, Koti RS, Mikhailidis DP, Seifalian AM, Davidson BR. Continuous infusion of N-acetylcysteine reduces liver warm ischaemia-reperfusion injury. Br J Surg 2004; 91: 1330-1339.
57. Dunschede F, Erbes K, Kircher A,Westermann S, Schad A, Riegler N et al. Protection from hepatic ischemia/reperfusion injury and improvement of liver regeneration by alpha-lipoic acid. Shock 2007; 27: 644-651.
58. Sewerynek E, Reiter RJ, Melchiorri D, Oritz GG, Lewinski A. Oxidative damage in the liver induced by ischemia-reperfusion: protection by melatonin. Hepatogastroenterology 1996; 43: 898-905.
59. Liu PG, He SQ, Zhang YH,Wu J. Protective effects of apocynin and allopurinol on ischemia/reperfusion-induced liver injury in mice. World J Gastroenterol 2008; 14: 2832-2837.
60. KarwinksiW, Søreide O. Allopurinol improves scavenging ability of the liver after ischemia/reperfusion injury. Liver 1997; 17: 139-143.
61. Shiratori Y, Kiriyama H, Fukushi Y, Nagura T, Takada H, Hai K et al. Modulation of ischemia-reperfusion-induced hepatic injury by Kupffer cells. Dig Dis Sci 1994; 39: 1265-1272.
62. Colletti LM, Remick DG, Campbell DA Jr. Desferal attenuates TNF release following hepatic ischemia/reperfusion. J Surg Res 1994; 57: 447-453.
63. Toledo-Pereyra LH, Lopez-Neblina F, Reuben JS, Toledo AH,Ward PA. Selectin inhibition modulates Akt/MAPK signaling and chemokine expression after liver ischemia-reperfusion. J Invest Surg 2004; 17: 303-313.
64. Takeyoshi I, Sunose Y, Iwazaki S, Tsutsumi H, Aiba M, Kasahara M et al. The effect of a selective cyclooxygenase-2 inhibitor in extended liver resection with ischemia in dogs. J Surg Res 2001; 100: 25-31. (Pubitemid 32802699)
65. Harada N, Okajima K, Kushimoto S. Gabexate mesilate, a synthetic protease inhibitor, reduces ischemia/reperfusion injury of rat liver by inhibiting leukocyte activation. Crit Care Med 1999; 27: 1958-1964.
66. Shito M, Wakabayashi G, Ueda M, Shimazu M, Shirasugi N, Endo M et al. Interleukin 1 receptor blockade reduces tumor necrosis factor production, tissue injury, and mortality after hepatic ischemia-reperfusion in the rat. Transplantation 1997; 63: 143-148.
67. Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, Edwards MJ. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and Kupffer cells. Hepatology 1998; 27: 507-512.
68. Glanemann M, Münchow S, Schirmeier A, Al-Abadi H, Lippek F, Langrehr JM et al. Steroid administration before partial hepatectomy with temporary inflow occlusion does not influence cyclin D1 and Ki-67 related liver regeneration. Langenbecks Arch Surg 2004; 389: 380-386.
69. Arias-Diaz J, Ildefonso JA, Muñoz JJ, Zapata A, Jiménez E. Both tacrolimus and sirolimus decrease Th1/Th2 ratio, and increase regulatory T lymphocytes in the liver after ischemia/reperfusion. Lab Invest 2009; 89: 433-445.
70. Kawano K, Kim YI, Kai T, Ishii T, Tatsuma T, Morimoto A et al. Evidence that FK506 alleviates ischemia/reperfusion injury to the rat liver: in vivo demonstration for suppression of TNF-a production in response to endotoxemia. Eur Surg Res 1994; 26: 108-115.
71. Chen MF, Chen JC, Chiu DF, Ng CJ, Shyr MH, Chen HM. Prostacylin analogue (OP-2507) induces delayed ex vivo neutrophil apoptosis and attenuates reperfusion-induced hepatic microcirculatory derangement in rats. Shock 2001; 16: 473-478.
72. Pannen BH, Köhler N, Hole B, Bauer M, Clemens MG, Geiger KK. Protective role of endogenous carbon monoxide in hepatic microcirculatory dysfunction after hemorrhagic shock. J Clin Invest 1998; 102: 1220-1228.
73. Uhlmann D, Armann B, Gaebel G, Ludwig S, Hess J, Pietsch UC et al. Endothelin A receptor blockade reduces hepatic ischemia/reperfusion injury after warm ischemia in a pig model. J Gastrointest Surg 2003; 7: 331-339. (Pubitemid 36875771)
74. Bataller R, Ginès P, Nicolás JM, Görbig MN, Garcia-Ramallo E, Gasull X et al. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 2000; 118: 1149-1156.
75. Hanazaki K, Kuroda T, Kajikawa S, Amano J. Prostaglandin E1 reduces thromboxane A2 in hepatic ischemia-reperfusion. Hepatogastroenterology 2000; 47: 807-811.
76. Uhlmann D, Scommotau S,Witzigmann H, Spiegel HU. Exogenous L-arginine protects liver microcirculation from ischemia reperfusion injury. Eur Surg Res 1998; 30: 175-184.
77. Suematsu M, Wakabayashi Y, Ishimura Y. Gaseous monoxides: a new class of microvascular regulator in the liver. Cardiovasc Res 1996; 32: 679-686.
78. Freise H, Palmes D, Spiegel HU. Inhibition of angiotensin-converting enzyme reduces rat liver reperfusion injury via bradykinin-2-receptor. J Surg Res 2006; 134: 231-237.
79. Hossain MA, Izuishi K, Maeta H. Effect of short-term administration of prostaglandin E1 on viability after ischemia/reperfusion injury with extended hepatectomy in cirrhotic rat liver. World J Surg 2003; 27: 1155-1160.
80. Lemasters JJ, Nieminen AL, Qian T, Trost LC, Elmore SP, Nishimura Y et al. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1998; 1366: 177-196. (Pubitemid 28467031)
81. Cursio R, Gugenheim J, Ricci JE, Crenesse D, Rostagno P, Maulon L et al. A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis. FASEB J 1999; 13: 253-261.
82. Nakajima H, Mizuta N, Fujiwara I, Sakaguchi K, Ogata H, Magae J et al. Blockade of the Fas/Fas ligand interaction suppresses hepatocyte apoptosis in ischemia-reperfusion rat liver. Apoptosis 2008; 13: 1013-1021.
83. Nagai S, Asoh S, Kobayashi Y, Shidara Y, Mori T, Suzuki M et al. Protection of hepatic cells from apoptosis induced by ischemia/reperfusion injury by protein therapeutics. Hepatol Res 2007; 37: 133-142.
84. Teoh N, Leclercq I, Pena AD, Farrell G. Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning. Hepatology 2003; 37: 118-128.
85. Howell JG, Zibari GB, Brown MF, Burney DL, Sawaya DE, Olinde JG et al. Both ischemic and pharmacological preconditioning decrease hepatic leukocyte/endothelial cell interactions. Transplantation 2000; 69: 300-303.
86. Peralta C, Hotter G, ClosaD, Prats N, Xaus C, Gelpí E et al. The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors. Hepatology 1999; 29: 126-132.
87. Peralta C, Rull R, Rimola A, Deulofeu R, Roselló-Catafau J, Gelpí E et al. Endogenous nitric oxide and exogenous nitric oxide supplementation in hepatic ischemia-reperfusion injury in the rat. Transplantation 2001; 71: 529-536.
88. Xue H, GuoH, Li YC, Hao ZM. Heme oxygenase-1 induction by hemin protects liver cells from ischemia/reperfusion injury in cirrhotic rats. World J Gastroenterol 2007; 13: 5384-5390.
89. Ito K, Ozasa H, Sanada K, Horikawa S. Doxorubicin preconditioning: a protection against rat hepatic ischemia-reperfusion injury. Hepatology 2000; 31: 416-419.
90. Rensing H, Bauer I, Kubulus D, Wolf B, Winning J, Ziegeler S et al. Heme oxygenase-1 gene expression in pericentral hepatocytes through beta1-adrenoceptor stimulation. Shock 2004; 21: 376-387.
91. Lai IR, Chang KJ, Tsai HW, Chen CF. Pharmacological preconditioning with simvastatin protects liver from ischemia-reperfusion injury by heme oxygenase-1 induction. Transplantation 2008; 85: 732-738.
92. Kulhanek-Heinze S, Gerbes AL, Gerwig T, Vollmar AM, Kiemer AK. Protein kinase A dependent signalling mediates anti-apoptotic effects of the atrial natriuretic peptide in ischemic livers. J Hepatol 2004; 41: 414-420.
93. Gerwig T, Meissner H, Bilzer M, Kiemer AK, Arnholdt H, Vollmar AM et al. Atrial natriuretic peptide preconditioning protects against hepatic preservation injury by attenuating necrotic and apoptotic cell death. J Hepatol 2003; 39: 341-348.
94. Lorsomradee S, Cromheecke S, Lorsomradee S, De Hert SG. Cardioprotection with volatile anesthetics in cardiac surgery. Asian Cardiovasc Thorac Ann 2008; 16: 256-264.
95. Schmidt R, Trischler E, Hoetzel A, Loop T, Humar M, Halverscheid L et al. Heme oxygenase-1 induction by the clinically used anesthetic isoflurane protects rat livers from ischemia/reperfusion injury. Ann Surg 2007; 245: 931-942.
96. Clavien PA, Selzner M, Rüdiger HA, Graf R, Kadry Z, Rousson V et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003; 238: 843-850.
97. Choukèr A, Schachtner T, Schauer R, Dugas M, Löhe F, Martignoni A et al. Effects of Pringle manoeuvre and ischaemic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: a randomized trial. Br J Anaesth 2004; 93: 204-211.
98. Nuzzo G, Giuliante F, Vellone M, De Cosmo G, Ardito F, Murario M et al. Pedicle camping with ischemic preconditioning in liver resection. Liver Transpl 2004; 10: S53-S57.
99. Li SQ, Liang LJ, Huang JF, Li Z. Ischemic preconditioning protects liver from hepatectomy under hepatic inflow occlusion for hepatocellular carcinoma patients with cirrhosis. World J Gastroenterol 2004; 10: 2580-2584.
100. Azoulay D, Lucidi V, Andreani P, Maggi U, Sebagh M, Ichai P et al. Ischemic preconditioning for major liver resection under vascular exclusion of the liver preserving the caval flow: a randomized prospective study. J Am Coll Surg 2006; 202: 203-211.
101. Heizmann O, Loehe F, Volk A, Schauer RJ. Ischemic preconditioning improves postoperative outcome after liver resections: a randomized controlled study. Eur J Med Res 2008; 13: 79-86.
102. Belghiti J, Noun R, Malafosse R, Jagot P, Sauvanet A, Pierangeli F et al. Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann Surg 1999; 229: 369-375.
103. Capussotti L, Nuzzo G, Polastri R, Giuliante F, Muratore A, Giovannini I. Continuous versus intermittent portal triad clamping during hepatectomy in cirrhosis. Results of a prospective, randomized clinical trial. Hepatogastroenterology 2003; 50: 1073-1077.
104. Esaki M, Sano T, Shimada K, Sakamoto Y, Takahashi Y, Wakai K et al. Randomized clinical trial of hepatectomy using intermittent pedicle occlusion with ischaemic intervals of 15 versus 30 minutes. Br J Surg 2006; 93: 944-951.
105. Brooks AJ, Hammond JS, Girling K, Beckingham IJ. The effect of hepatic vascular inflow occlusion on liver tissue pH, carbon dioxide, and oxygen partial pressures: defining the optimal clamp/release regime for intermittent portal clamping. J Surg Res 2007; 141: 247-251.
106. Smyrniotis V, Theodoraki K, Arkadopoulos N, Fragulidis G, Condi-Pafiti A, Plemenou-Fragou M et al. Ischemic preconditioning versus intermittent vascular occlusion in liver resections performed under selective vascular exclusion: a prospective randomized study. Am J Surg 2006; 192: 669-674.
107. Petrowsky H, McCormack L, Trujillo M, Selzner M, Jochum W, Clavien PA. A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection. Ann Surg 2006; 244: 921-928.
108. Yadav SS, Sindram D, Perry DK, Clavien PA. Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepatology 1999; 30: 1223-1231.
109. Clavien PA, Yadav S, Sindram D, Bentley RC. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 2000; 232: 155-162.
110. Choukèr A, Martignoni A, Schauer R, Dugas M, Rau HG, Jauch KWet al. Beneficial effects of ischemic preconditioning in patients undergoing hepatectomy: the role of neutrophils. Arch Surg 2005; 140: 129-136.
111. Choukèr A, Martignoni A, Schauer RJ, Dugas M, Schachtner T, Kaufmann I et al. Alpha-gluthathione S-transferase as an early marker of hepatic ischemia/reperfusion injury after liver resection. World J Surg 2005; 29: 528-534.
112. Gurusamy KS, Kumar Y, Sharma D, Davidson BR. Methods of vascular occlusion for elective liver resections. Cochrane Database Sys Rev 2007; (4)CD006409.
113. Makuuchi M, Mori T, Gunvén P, Yamazaki S, Hasegawa H. Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet 1987; 164: 155-158.
114. Sakamoto Y, Makuuchi M, Takayama T, Minagawa M, Kita Y. Pringle's maneuver lasting 322 min. Hepatogastroenterology 1999; 46: 457-458.
115. Wu CC, Hwang CR, Liu TJ, P'eng FK. Effects and limitations of prolonged intermittent ischaemia for hepatic resection of the cirrhotic liver. Br J Surg 1996; 83: 121-124.
116. Man K, Fan ST,Ng IO, Lo CM, Liu CL, YuWC et al. Tolerance of the liver to intermittent Pringle maneuver in hepatectomy for liver tumors. Arch Surg 1999; 134: 533-539.
117. Elias D, Desruennes E, Lasser P. Prolonged intermittent clamping of the portal triad during hepatectomy. Br J Surg 1991; 78: 42-44.
118. Cerwenka H, Bacher H, Werkgartner G, El-Shabrawi A, Quehenberger F, Hauser H et al. Antioxidant treatment during liver resection for alleviation of ischemia- reperfusion injury. Hepatogastroenterology 1998; 45: 777-782.
119. Vriens MR, Marinelli A, Harinck HI, Zwinderman KH, van de Velde CJ. The role of allopurinol in human liver ischemia/reperfusion injury: a prospective randomized clinical trial. Hepatogastroenterology 2002; 49: 1069-1073.
120. Bartels M, Biesalski HK, Engelhart K, Sendlhofer G, Rehak P, Nagel E. Pilot study on the effect of parenteral vitamin E on ischemia and reperfusion induced liver injury: a double blind, randomized, placebo-controlled trial. Clin Nutr 2004; 23: 1360-1370.
121. Dünschede F, Erbes K, Kircher A, Westermann S, Seifert J, Schad A et al. Reduction of ischemia reperfusion injury after liver resection and hepatic inflow occlusion by alpha-lipoic acid in humans. World J Gastroenterol 2006; 12: 6812-6817.
122. Kostopanagiotou G, Pandazi AK, Andreadou I, Markantonis SL, Niokou D, Teloudis A et al. Effects of mannitol in the prevention of lipid peroxidation during liver resection with hepatic vascular exclusion. J Clin Anesth 2006; 18: 570-574.
123. Kim YI, Chung HJ, Song KE, Hwang YJ, Lee JW, Lee YJ et al. Evaluation of a protease inhibitor in the prevention of ischemia and reperfusion injury in hepatectomy under intermittent Pringle maneuver. Am J Surg 2006; 191: 72-76.
124. Muratore A, Ribero D, Ferrero A, Bergero R, Capussotti L. Prospective randomized study of steroids in the prevention of ischaemic injury during hepatic resection with pedicle clamping. Br J Surg 2003; 90: 17-22.
125. Aldrighetti L, Pulitanò C, Arru M, Finazzi R, Catena M, Soldini L et al. Impact of preoperative steroids administration on ischemia-reperfusion injury and systemic responses in liver surgery: a prospective randomized study. Liver Transpl 2006; 12: 941-949.
126. Pulitanò C, Aldrighetti L, Arru M, Finazzi R, Soldini L, Catena M et al. Prospective randomized study of the benefits of preoperative corticosteroid administration on hepatic ischemia-reperfusion injury and cytokine response in patients undergoing hepatic resection. HPB 2007; 9: 183-189.
127. Shirabe K, Takenaka K, Yamamoto K, Kitamura M, Itasaka H, Matsumata T et al. The role of prostanoid in hepatic damage during hepatectomy. Hepatogastroenterology 1996; 43: 596-601.
128. Sugawara Y, Kubota K, Ogura T, Esumi H, Inoue K, Takayama T et al. Protective effect of prostaglandin E1 against ischemia/reperfusion-induced liver injury: results of a prospective, randomized study in cirrhotic patients undergoing subsegmentectomy. J Hepatol 1998; 29: 969-976.
129. Orii R, Sugawara Y, Hayashida M, Yamada Y, Chang K, Takayama T et al. Effects of amrinone on ischaemia-reperfusion injury in cirrhotic patients undergoing hepatectomy: a comparative study with prostaglandin E1. Br J Anaesth 2000; 85: 389-395.
130. Beck-Schimmer B, Breitenstein S, Urech S, De Conno E, Wittlinger M, Puhan M et al. A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg 2008; 248: 909-918.
131. Tang L, Tian F, Tao W, Cui J. Hepatocellular glycogen in alleviation of liver ischemia-reperfusion injury during partial hepatectomy. World J Surg 2007; 31: 2039-2043.
132. Cerwenka H, Khoschsorur G, Bacher H, Werkgartner G, El-Shabrawi A, Quehenberger F et al. Normothermic liver ischemia and antioxidant treatment during hepatic resections. Free Radic Res 1999; 30: 463-439.
133. Ghibu S, Richard C, Vergely C, Zeller M, Cottin Y, Rochette L. Antioxidant properties of an endogenous thiol: alpha-lipoic acid, useful in the prevention of cardiovascular diseases. J Cardiovasc Pharmacol 2009; 54: 391-398.
134. Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci 1998; 94: 557-572.
135. Sauerland S, Nagelschmidt M, Mallmann P, Neugebauer EA. Risks and benefits of preoperative high dose methylprednisolone in surgical patients: a systematic review. Drug Saf 2000; 23: 449-461.
136. Pâques EP, Römisch J. Comparative study on the in vitro effectiveness of antithrombotic agents. Thromb Res 1991; 64: 11-21.
137. Kim YI, Fujita S, Hwang YJ, Chun JM, Song KE, Chun BY. Successful intermittent application of the Pringle maneuver for 30 minutes during human hepatectomy: a clinical randomized study with use of a protease inhibitor. Hepatogastroenterology 2007; 54: 2055-2060.
138. Müllenheim J, Ebel D, Frässdorf J, Preckel B, Thämer V, Schlack W. Isoflurane preconditions myocardium against infarction via release of free radicals. Anesthesiology 2002; 96: 934-940.
139. Tanaka K, Ludwig LM, Kersten JR, Pagel PS, Waritier DC. Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology 2004; 100: 707-721.
140. van der Bilt JD, Kranenburg O, Nijkamp MW, Smakman N, Veenendaal LM, Te Velde EA et al. Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model. Hepatology 2005; 42: 165-175.
141. van der Bilt JD, Kranenburg O, Verheem A, van Hillegersberg R, Borel Rinkes IH. Selective portal clamping to minimize hepatic ischaemia-reperfusion damage and avoid accelerated outgrowth of experimental colorectal liver metastases. Br J Surg 2006; 93: 1015-1022.
142. Ypsilantis P, Lambropoulou M, Tentes I, Anagnostopoulos K, Tsigalou C, Papadopoulos N et al. Impaired liver regeneration following partial hepatectomy using the Pringle maneuver: protective effect of mesna. J Gastroenterol Hepatol 2009; 24: 623-632.
143. Yamada F, Saito T, Abe T, Tsuchiya T, Sato Y, Kenjo A et al. Ischemic preconditioning enhances regenerative capacity of hepatocytes in long-term ischemically damaged rat livers. J Gastroenterol Hepatol 2007; 22: 1971-1977.